B. B. Fuks - Concepedia

Author

B. B. Fuks

UCB Pharma (Belgium)

Also Known As

B B FUKS, B B Fuks, B. B. FUKS, B. B. Fuks, B. FUKS, B. Fuks, B.B. Fuks, Bruno FUKS, Bruno Fuks

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

UCB Pharma (Belgium)Université Libre de Bruxelles Rutgers, The State University of New Jersey

About

B. B. Fuks is an author at UCB Pharma (Belgium) specializing in medicine, pharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	2.5K
2	Natural Sciences	3	3	252
3	Engineering	1	1	46
4	Health Sciences	1	1	12
5	Public Health	1	1	17

B. B. Fuks

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam Berkley A. Lynch, Nathalie Lambeng, Karl Nocka, Proceedings of the National Academy of Sciences New Antiepileptic DrugMolecular NeuroscienceAntiepileptic Drug LevetiracetamNeurophysiologyMedicine	2004	1.6K
Tic20 and Tic22 Are New Components of the Protein Import Apparatus at the Chloroplast Inner Envelope Membrane Andrei Kouranov, Xuejun Chen, B. B. Fuks, The Journal of Cell Biology	1998	267
Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties Michel Gillard, B. B. Fuks, Karine Leclercq, European Journal of Pharmacology NeurophysiologyMedicineNeurotransmitterNeuropeptide ReceptorNeuropharmacology	2011	238
Discovery of 4-Substituted Pyrrolidone Butanamides as New Agents with Significant Antiepileptic Activity Benoît Kenda, Alain Matagne, Patrice Talaga, Journal of Medicinal Chemistry New AgentsDrug TargetPharmaceutical ScienceLbs AffinityPharmacotherapy	2003	222
Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein Michel Gillard, Pierre Chatelain, B. B. Fuks European Journal of Pharmacology Synaptic SignalingMedicineSynaptic TransmissionNeurotransmitterNeuropharmacology	2006	146
Comparative Study of Membrane Potential-Sensitive Fluorescent Probes and their Use in Ion Channel Screening Assays Christian Wolff, B. B. Fuks, Pierre Chatelain SLAS DISCOVERY	2003	111
Mitochondria permeability transition-dependent tert-butyl hydroperoxide-induced apoptosis in hepatoma HepG2 cells Jean‐Pascal Piret, Thierry Arnould, B. B. Fuks, Biochemical Pharmacology Mitochondrial FunctionBiochemistryHepatoma Hepg2 CellsLiver PhysiologyLipid Peroxidation	2003	68
Binding characteristics of [3H]ucb 30889 to levetiracetam binding sites in rat brain Michel Gillard, B. B. Fuks, Philippe Michel, European Journal of Pharmacology BiochemistryNeurophysiologyMedicineNeuropeptide ReceptorNeuropharmacology	2003	61
Mechanism of Protein Transport across the Chloroplast Envelope B. B. Fuks, Danny J. Schnell PLANT PHYSIOLOGY Membrane TransportProtein TransportMolecular Biology	1997	59
Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell lines B. B. Fuks, Michel Gillard, Philippe Michel, European Journal of Pharmacology OptogeneticsPhotoaffinity LabellingBiochemistryNeurophysiologyNeuroanatomy	2003	59

Page 1